Chong Geng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chong Geng has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Kailin Liu
Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
4 shared publicationsBaoyan Zhao
Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
2 shared publicationsPeng Zhao
Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
2 shared publicationsZhihao Wang
Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
2 shared publicationsJintao Mb Ren
Minquan County People’s Hospital, Shangqiu, Henan, China
1 shared publicationJu Liu
Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
1 shared publication
Latest Publications
- Open Access
- 16 October 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1570796
Case Report: Diagnosis and treatment of giant thoracodorsal liposarcoma
Rationale: Liposarcoma is a prevalent malignant tumor of soft tissue; however, those in the thoracic and back regions are rare, and surgery is particularly challenging due to their complex anatomical structures.Case presentation: A 90-year-old man was admitted to the hospital due to a massive lump in the thoracodorsal region. Computerized tomography imaging revealed a large heterogeneous lesion with lipid density in the left axillary chest wall area, with a maximum cross-sectional area of approximately 17.4 × 14.2 cm. The histopathologic report showed a well-differentiated liposarcoma.Clinical discussion: Early detection and timely intervention of liposarcoma are critical, particularly for large liposarcomas in the thoracodorsal region because of the surrounding vital structures, such as the brachial plexus, axillary vein, and axillary artery. We found that the liposarcoma was infiltrated by M2 macrophages, with the central region exhibiting high rates of M0 macrophages and Treg cells. This immunosuppressive tumor microenvironment may provide a potential target for the development of immunotherapeutic strategies.
- 16 October 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1570796
Open AccessCase Report: Diagnosis and treatment of giant thoracodorsal liposarcoma
Rationale: Liposarcoma is a prevalent malignant tumor of soft tissue; however, those in the thoracic and back regions are rare, and surgery is particularly challenging due to their complex anatomical structures.Case presentation: A 90-year-old man was admitted to the hospital due to a massive lump in the thoracodorsal region. Computerized tomography imaging revealed a large heterogeneous lesion with lipid density in the left axillary chest wall area, with a maximum cross-sectional area of approximately 17.4 × 14.2 cm. The histopathologic report showed a well-differentiated liposarcoma.Clinical discussion: Early detection and timely intervention of liposarcoma are critical, particularly for large liposarcomas in the thoracodorsal region because of the surrounding vital structures, such as the brachial plexus, axillary vein, and axillary artery. We found that the liposarcoma was infiltrated by M2 macrophages, with the central region exhibiting high rates of M0 macrophages and Treg cells. This immunosuppressive tumor microenvironment may provide a potential target for the development of immunotherapeutic strategies.
- Open Access
- 3 September 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1594781
Preoperative serum indicators as predictors of postoperative hypoparathyroidism following thyroidectomy
Background: Hypoparathyroidism is a frequent complication following thyroidectomy. However, the risk factors for postoperative hypoparathyroidism remain poorly characterized. This study aims to investigate routine clinical characteristics to identify predictors of postoperative hypoparathyroidism.Methods: A retrospective analysis was conducted on 3,638 patients who underwent total or hemithyroidectomy with isthmusectomy through open surgery with routine central lymph node dissection. Based on postoperative serum parathyroid hormone(PTH) levels, patients were subdivided according to the normal reference PTH levels or the Q3 quartile of PTH decline rate. Spearman correlation analysis and stepwise multiple linear regression were used to identify factors affecting preoperative serum PTH levels. Univariate and multivariate logistic regression analyses were performed to explore risk factors for postoperative hypoparathyroidism.Results: Among patients developed postoperative hypoparathyroidism. Multivariate logistic regression revealed that Hashimoto’s thyroiditis (HT) (OR=1.786, P=0.007) and preoperative blood glucose (OR=1.319, P=0.005) was an independent risk factor, while body mass index (BMI)≥24 (OR=0.714, P=0.032),elevated preoperative PTH levels (OR=0.988, P=0.013)and male (OR=0.554, P=0.002) were protective factors. Among patients in the Q3 quartile,postoperative PTH decline rate was positively associated with HT (OR=2.266, P<0.001), preoperative PTH levels (OR=1.032, P<0.001), and blood glucose (OR=1.234, P=0.027), while it was negatively associated with BMI≥24 (OR=0.611, P=0.013), hemoglobin (OR=0.984, P=0.003), and high-density lipoprotein cholesterol (HDL-C) (OR=0.426, P=0.007).Additionally, male (OR=0.558, P=0.003) and preoperative serum Ca2+ levels (OR=0.110, P=0.011) were negatively correlated with the postoperative PTH decline rate in patients undergoing hemithyroidectomy with isthmusectomy. Furthermore, age had no significant effect on the incidence of postoperative hypoparathyroidism.Conclusions: This study demonstrates that preoperative high glucose levels and HT are risk factors for hypoparathyroidism after total thyroidectomy, while BMI≥24 serves as a protective factor against postoperative hypoparathyroidism. Additionally, female is a risk factor for hypoparathyroidism after both total thyroidectomy and hemithyroidectomy with isthmusectomy, while higher hemoglobin levels and HDL-C are negatively correlated with the decline in PTH levels after total thyroidectomy.
- 3 September 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1594781
Open AccessPreoperative serum indicators as predictors of postoperative hypoparathyroidism following thyroidectomy
Background: Hypoparathyroidism is a frequent complication following thyroidectomy. However, the risk factors for postoperative hypoparathyroidism remain poorly characterized. This study aims to investigate routine clinical characteristics to identify predictors of postoperative hypoparathyroidism.Methods: A retrospective analysis was conducted on 3,638 patients who underwent total or hemithyroidectomy with isthmusectomy through open surgery with routine central lymph node dissection. Based on postoperative serum parathyroid hormone(PTH) levels, patients were subdivided according to the normal reference PTH levels or the Q3 quartile of PTH decline rate. Spearman correlation analysis and stepwise multiple linear regression were used to identify factors affecting preoperative serum PTH levels. Univariate and multivariate logistic regression analyses were performed to explore risk factors for postoperative hypoparathyroidism.Results: Among patients developed postoperative hypoparathyroidism. Multivariate logistic regression revealed that Hashimoto’s thyroiditis (HT) (OR=1.786, P=0.007) and preoperative blood glucose (OR=1.319, P=0.005) was an independent risk factor, while body mass index (BMI)≥24 (OR=0.714, P=0.032),elevated preoperative PTH levels (OR=0.988, P=0.013)and male (OR=0.554, P=0.002) were protective factors. Among patients in the Q3 quartile,postoperative PTH decline rate was positively associated with HT (OR=2.266, P<0.001), preoperative PTH levels (OR=1.032, P<0.001), and blood glucose (OR=1.234, P=0.027), while it was negatively associated with BMI≥24 (OR=0.611, P=0.013), hemoglobin (OR=0.984, P=0.003), and high-density lipoprotein cholesterol (HDL-C) (OR=0.426, P=0.007).Additionally, male (OR=0.558, P=0.003) and preoperative serum Ca2+ levels (OR=0.110, P=0.011) were negatively correlated with the postoperative PTH decline rate in patients undergoing hemithyroidectomy with isthmusectomy. Furthermore, age had no significant effect on the incidence of postoperative hypoparathyroidism.Conclusions: This study demonstrates that preoperative high glucose levels and HT are risk factors for hypoparathyroidism after total thyroidectomy, while BMI≥24 serves as a protective factor against postoperative hypoparathyroidism. Additionally, female is a risk factor for hypoparathyroidism after both total thyroidectomy and hemithyroidectomy with isthmusectomy, while higher hemoglobin levels and HDL-C are negatively correlated with the decline in PTH levels after total thyroidectomy.
- Open Access
- 1 July 2024
- Published by Arts and Science Press Pte. Ltd. in Micromaterials and Interfaces
- Vol. 2 (1) , 6307
Effect of Ti3C2-MXene size on cell viability of human carcinoma cells
MXene nanoflakes, a new type of transition metal carbides, nitrides, and carbonitrides (named as MXene) have emerged as biocompatible transition metal structures, which illustrate desirable performance for various applications due to their unique physicochemical, and compositional virtues. MXenes are currently expanding their application from optical, chemical, electronic, and mechanical fields towards biomedical areas. In terms of biomedical applications, the biological toxicity of MXenes materials in different forms must be considered inevitably. In this paper, Ti3C2-MXene nanoflakes with different sizes have been prepared by means of wet etching method combined with powerful ultrasonication for exploring the effect in human breast carcinoma cells (MDA-MB-231 Cells) and human thyroid carcinoma cells (GLAG-66 Cells). Clinically representative MDA-MB-231 Cells and GLAG-66 Cells are selected as experimental subjects and their biotoxicities are characterized when exposed to Ti3C2-MXene nanoflakes with different sizes and concentrations. The results show that Ti3C2-MXene nanoflakes with sizes below 200 nm is almost non-toxic to MDA-MB-231 Cells and GLAG-66 Cells at low concentrations, and enhance their bioactivity and proliferation. When the nanoflake size is above 200 nm, Ti3C2-MXene has a significant inhibitory effect on the proliferation of the cells. This phenomenon may be due to the different roles of Ti3C2-MXene materials at different scales in cell proliferation as well as in complex physiological processes. This result is of great significance for material screening and design before biological experiments using Ti3C2-MXene.
- 1 July 2024
- Published by Arts and Science Press Pte. Ltd. in Micromaterials and Interfaces
- Vol. 2 (1) , 6307
Open AccessEffect of Ti3C2-MXene size on cell viability of human carcinoma cells
MXene nanoflakes, a new type of transition metal carbides, nitrides, and carbonitrides (named as MXene) have emerged as biocompatible transition metal structures, which illustrate desirable performance for various applications due to their unique physicochemical, and compositional virtues. MXenes are currently expanding their application from optical, chemical, electronic, and mechanical fields towards biomedical areas. In terms of biomedical applications, the biological toxicity of MXenes materials in different forms must be considered inevitably. In this paper, Ti3C2-MXene nanoflakes with different sizes have been prepared by means of wet etching method combined with powerful ultrasonication for exploring the effect in human breast carcinoma cells (MDA-MB-231 Cells) and human thyroid carcinoma cells (GLAG-66 Cells). Clinically representative MDA-MB-231 Cells and GLAG-66 Cells are selected as experimental subjects and their biotoxicities are characterized when exposed to Ti3C2-MXene nanoflakes with different sizes and concentrations. The results show that Ti3C2-MXene nanoflakes with sizes below 200 nm is almost non-toxic to MDA-MB-231 Cells and GLAG-66 Cells at low concentrations, and enhance their bioactivity and proliferation. When the nanoflake size is above 200 nm, Ti3C2-MXene has a significant inhibitory effect on the proliferation of the cells. This phenomenon may be due to the different roles of Ti3C2-MXene materials at different scales in cell proliferation as well as in complex physiological processes. This result is of great significance for material screening and design before biological experiments using Ti3C2-MXene.
- Open Access
- 16 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (7) , e37246
Postoperative recurrence of diffuse sclerosing thyroid cancer in an adolescent patient: A case report
Background: Papillary thyroid cancer is an inert malignant tumor with a good response to surgical treatment, low recurrence and metastasis rate, and good prognosis. Diffuse sclerosing thyroid cancer is an invasive subtype that is more common in young people, with a higher rate of lymph node metastasis and recurrence, and a relatively poor prognosis. Patient concerns: A 13-year-old girl underwent radical surgery for diffuse sclerosing thyroid cancer. Eight years later, due to a large number of lymph node metastases, she underwent another radical surgery on her neck lymph nodes. Methods: The patient thyroid ultrasound and neck enhanced CT indicated that the patient had multiple enlarged lymph nodes in the neck with irregular morphology and structure, and the possibility of metastatic lymph nodes was high. Subsequently, the patient underwent thyroid fine-needle aspiration and the results showed that cancer cells were detected in both cervical lymph nodes. Diagnosis: The patient was diagnosed with bilateral cervical lymph node metastases after thyroid surgery. Results: After the second surgery, the patient recovered well, and no residual or focal iodine uptake tissue was found on the enhanced CT examination. Conclusion: As diffuse sclerosing thyroid cancer is prone to lymph node and recurrent metastases, once it is diagnosed, radical treatment should be actively performed. Postoperative adjuvant radiation therapy should be administered according to the patient condition and regular follow-ups should be conducted to monitor neck lymph node metastasis.
- 16 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (7) , e37246
Open AccessPostoperative recurrence of diffuse sclerosing thyroid cancer in an adolescent patient: A case report
Background: Papillary thyroid cancer is an inert malignant tumor with a good response to surgical treatment, low recurrence and metastasis rate, and good prognosis. Diffuse sclerosing thyroid cancer is an invasive subtype that is more common in young people, with a higher rate of lymph node metastasis and recurrence, and a relatively poor prognosis. Patient concerns: A 13-year-old girl underwent radical surgery for diffuse sclerosing thyroid cancer. Eight years later, due to a large number of lymph node metastases, she underwent another radical surgery on her neck lymph nodes. Methods: The patient thyroid ultrasound and neck enhanced CT indicated that the patient had multiple enlarged lymph nodes in the neck with irregular morphology and structure, and the possibility of metastatic lymph nodes was high. Subsequently, the patient underwent thyroid fine-needle aspiration and the results showed that cancer cells were detected in both cervical lymph nodes. Diagnosis: The patient was diagnosed with bilateral cervical lymph node metastases after thyroid surgery. Results: After the second surgery, the patient recovered well, and no residual or focal iodine uptake tissue was found on the enhanced CT examination. Conclusion: As diffuse sclerosing thyroid cancer is prone to lymph node and recurrent metastases, once it is diagnosed, radical treatment should be actively performed. Postoperative adjuvant radiation therapy should be administered according to the patient condition and regular follow-ups should be conducted to monitor neck lymph node metastasis.
- Open Access
- 27 February 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1094379
Preoperative ultrasound identification and localization of the inferior parathyroid glands in thyroid surgery
Introduction: The parathyroid glands are important endocrine glands for maintaining calcium and phosphorus metabolism, and they are vulnerable to accidental injuries during thyroid cancer surgery. The aim of this retrospective study was to investigate the application of high-frequency ultrasound imaging for preoperative anatomical localization of the parathyroid glands in patients with thyroid cancer and to analyze the protective effect of this technique on the parathyroid glands and its effect on reducing postoperative complications.Materials and methods: A total of 165 patients who were operated for thyroid cancer in our hospital were included. The patients were assigned into two groups according to the time period of surgery: Control group, May 2018 to February 2021 (before the application of ultrasound localization of parathyroid in our hospital); PUS group, March 2021 to May 2022. In PUS group, preoperative ultrasound was used to determine the size and location of bilateral inferior parathyroid glands to help surgeons identify and protect the parathyroid glands during operation. We compared the preoperative ultrasound results with the intraoperative observations. Preoperative and first day postoperative serum calcium and PTH were measured in both groups.Results: Our preoperative parathyroid ultrasound identification technique has more than 90% accuracy (true positive rate) to confirm the location of parathyroid gland compared to intraoperative observations. Postoperative biochemical results showed a better Ca2+ [2.12(0.17) vs. 2.05(0.31), P=0.03] and PTH [27.48(14.88) vs. 23.27(16.58), P=0.005] levels at first day post-operation in PUS group compared to control group. We also found a reduced risk of at least one type of hypoparathyroidism after surgery in control group:26 cases (31.0%) vs. 41 cases (50.6%), p=0.016.Conclusion: Ultrasound localization of the parathyroid glands can help in the localization, identification and in situ preservation of the parathyroid glands during thyroidectomy. It can effectively reduce the risk of hypoparathyroidism after thyroid surgery.
- 27 February 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1094379
Open AccessPreoperative ultrasound identification and localization of the inferior parathyroid glands in thyroid surgery
Introduction: The parathyroid glands are important endocrine glands for maintaining calcium and phosphorus metabolism, and they are vulnerable to accidental injuries during thyroid cancer surgery. The aim of this retrospective study was to investigate the application of high-frequency ultrasound imaging for preoperative anatomical localization of the parathyroid glands in patients with thyroid cancer and to analyze the protective effect of this technique on the parathyroid glands and its effect on reducing postoperative complications.Materials and methods: A total of 165 patients who were operated for thyroid cancer in our hospital were included. The patients were assigned into two groups according to the time period of surgery: Control group, May 2018 to February 2021 (before the application of ultrasound localization of parathyroid in our hospital); PUS group, March 2021 to May 2022. In PUS group, preoperative ultrasound was used to determine the size and location of bilateral inferior parathyroid glands to help surgeons identify and protect the parathyroid glands during operation. We compared the preoperative ultrasound results with the intraoperative observations. Preoperative and first day postoperative serum calcium and PTH were measured in both groups.Results: Our preoperative parathyroid ultrasound identification technique has more than 90% accuracy (true positive rate) to confirm the location of parathyroid gland compared to intraoperative observations. Postoperative biochemical results showed a better Ca2+ [2.12(0.17) vs. 2.05(0.31), P=0.03] and PTH [27.48(14.88) vs. 23.27(16.58), P=0.005] levels at first day post-operation in PUS group compared to control group. We also found a reduced risk of at least one type of hypoparathyroidism after surgery in control group:26 cases (31.0%) vs. 41 cases (50.6%), p=0.016.Conclusion: Ultrasound localization of the parathyroid glands can help in the localization, identification and in situ preservation of the parathyroid glands during thyroidectomy. It can effectively reduce the risk of hypoparathyroidism after thyroid surgery.